Assignee

OLAUSSEN KEN

FR1 patents

Top patents by PatentIndex Score

US9702875B2Jul 11, 2017

Expression of isoform 202 of ERCC1 for predicting response to cancer chemotherapy

OLAUSSEN KEN0 citations31